Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice

The therapeutic value of inhaled corticosteroids (ICSs) for COPD is limited. In published RCTs, ICS could be withdrawn in COPD patients without increasing exacerbation risk when bronchodilator treatment is optimized. Here we report on the feasibility and risks of ICS withdrawal in Dutch general prac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:NPJ Prim Care Respir Med
Autors principals: van den Bemt, Lisette, van den Nieuwenhof, Lotte, Rutjes, Anne, van der Meer, Victor, Stege, Gerben, Wensing, Michel, Teichert, Martina, Schermer, Tjard
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7547069/
https://ncbi.nlm.nih.gov/pubmed/33037200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41533-020-00198-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars